Obalon Therapeutics

Obalon Therapeutics

Signal active

Organization

Contact Information

Overview

Obalon is an engineering-driven medical technology company with a singular focus on innovative, high-quality gastric balloon technology. Located in San Diego, California, the technical team at Obalon has a long history of working closely with leading clinicians to develop innovative medical products that revolutionize the treatment of chronic disease. As a company, they believe in the fundamental value of imagination and invention, combined with rigorous testing and analysis, to ensure the highest levels of safety and performance. The result is a user-focused approach that deploys the power of advanced technological thinking to support clinical treatment objectives.

It was founded in 2008.

About

Industries

Health Care, Medical, Therapeutics

Founded

2008

Employees

51-100

Headquarters locations

Carlsbad, California, United States, North America

Social

Profile Resume

Obalon Therapeutics headquartered in United States, North America, operates in the Health Care, Medical, Therapeutics sector. The company focuses on Health Care and has secured $31.4B in funding across 156 round(s). With a team of 51-100 employees, Obalon Therapeutics is actively contributing to advancements in Health Care. Their latest funding round, Series C - Obalon Therapeutics, raised $16.5M. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace Steve Pacelli

Steve Pacelli

CEO

imagePlace Mark Brister

Mark Brister

VP of R&D

imagePlace Amy Vandenberg

Amy Vandenberg

Vice President of Regulatory Affairs

Funding Rounds

Funding rounds

13

Investors

3

Lead Investors

0

Total Funding Amount

$201.0M

Details

5

Obalon Therapeutics has raised a total of $201.0M in funding over 5 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2011Early Stage Venture
2016Late Stage Venture15.8M
2015Late Stage Venture20.0M
2012Late Stage Venture16.5M

Investors

Obalon Therapeutics is funded by 32 investors.

Investor NameLead InvestorFunding RoundPartners
InterWest Partners-FUNDING ROUND - InterWest Partners16.5M
Domain Associates-FUNDING ROUND - Domain Associates16.5M
Obalon Therapeutics-FUNDING ROUND - Obalon Therapeutics16.5M
Okapi Venture Capital-FUNDING ROUND - Okapi Venture Capital16.5M